Heba F Ashour

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 25, 2026
Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy.

|Jun 15, 2026
Triazole-Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025.

|Sep 27, 2025
Beyond ATP Synthase Inhibition: Chemical Diversification, Bioactivities, and Therapeutic Potential of Oligomycin A.

Mohamed S Nafie, Muna A Alshams, Mohamed K Diab

|Sep 10, 2025
A comprehensive review and recent advances on isatin-based compounds as a versatile framework for anticancer therapeutics (2020-2025).

Muna A Alshams, Mohamed S Nafie, Heba F Ashour

Pageof 1

Frequent Collaborators

4 joint publications

Mohamed S Nafie

4 joint publications

Asmaa S A Yassen

3 joint publications

Mohamed K Diab

2 joint publications

Muna A Alshams